Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hypoxic, anemic and cardiac hypoxemia: When does tissue hypoxia begin?

Deutsche medizinische Wochenschrift (1946)·2023

Same author

[Interdisciplinary Perspectives on the Role of Aerosol Transmission in SARS-CoV-2 Infections].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2022

Same author

Conservative management of COVID-19 associated hypoxaemia.

ERJ open research·2021

Same author

Conservative management of COVID-19 associated hypoxaemia.

ERJ open research·2021

Same author

Conservative management of COVID-19 associated hypoxaemia.

ERJ open research·2021

Same author

Bench testing of noninvasive ventilation masks with viral filters for the protection from inhalation of infectious respirable particles.

Journal of occupational and environmental hygiene·2021

Search research articles

Related Experiment Videos

[Clinical Year in Review - advanced COPD].

Dieter Köhler¹

¹Abteilung für Pneumologie I, Fachkrankenhaus Kloster Grafschaft, Schmallenberg-Grafschaft, Germany. d.koehler@fkkg.de

Medizinische Klinik (Munich, Germany : 1983)

|November 10, 2007

Summary

Chronic obstructive pulmonary disease (COPD) management involves oxygen therapy, antibiotics for bacterial colonization, and potentially opioids for severe dyspnea. Advanced options include noninvasive ventilation, physical training, and surgery for lung volume reduction.

Area of Science:

Pulmonology
Respiratory Medicine

Context:

Chronic obstructive pulmonary disease (COPD) affects a significant portion of smokers and older adults.
Disease severity ranges from mild to severe, with airway obstruction and emphysema as primary limitations.

Purpose:

To review current and emerging therapeutic strategies for managing COPD.
To highlight the benefits of various interventions, including oxygen therapy, antibiotics, pharmacotherapy, ventilation, exercise, and surgery.

Summary:

Oxygen therapy is crucial, especially for hypercapnic patients and during exercise for emphysema-predominant COPD.
Antibiotic therapy may benefit patients with chronic bacterial colonization, while opioids can manage severe dyspnea in specific patient groups.
Noninvasive ventilation, physical training, and surgical interventions like lung volume reduction surgery offer further management options.

Related Experiment Videos

Impact:

Optimized treatment strategies can improve quality of life and potentially prolong lifespan for COPD patients.
Ongoing research and clinical trials are essential for refining treatment protocols and assessing long-term outcomes.